KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Interest Coverage Ratio (2018 - 2026)

Castle Biosciences' Interest Coverage Ratio history spans 8 years, with the latest figure at 159.46 for Q4 2025.

  • On a quarterly basis, Interest Coverage Ratio fell 462.23% to 159.46 in Q4 2025 year-over-year; TTM through Dec 2025 was 497.79, a 3102.82% decrease, with the full-year FY2025 number at 497.79, down 3412.86% from a year prior.
  • Interest Coverage Ratio hit 159.46 in Q4 2025 for Castle Biosciences, up from 283.5 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for CSTL hit a ceiling of 44.02 in Q4 2024 and a floor of 15171.0 in Q4 2021.
  • Historically, Interest Coverage Ratio has averaged 3458.91 across 5 years, with a median of 1642.82 in 2025.
  • Biggest five-year swings in Interest Coverage Ratio: crashed 197543.3% in 2021 and later surged 101.56% in 2024.
  • Tracing CSTL's Interest Coverage Ratio over 5 years: stood at 15171.0 in 2021, then skyrocketed by 62.38% to 5708.0 in 2022, then surged by 50.44% to 2829.0 in 2023, then surged by 101.56% to 44.02 in 2024, then crashed by 462.23% to 159.46 in 2025.
  • Business Quant data shows Interest Coverage Ratio for CSTL at 159.46 in Q4 2025, 283.5 in Q3 2025, and 202.43 in Q2 2025.